www.rousselot.com Open in urlscan Pro
52.19.10.194  Public Scan

Form analysis
2 forms found in the DOM

GET /search-results

<form action="/search-results" method="get" class="navigationBarSearchForm js-navigationBarSearchForm" data-suggest="/search-results?type=7384" data-hs-cf-bound="true">
  <label for="navigationBarSearchForm-input" class="show-for-sr js-navigationBarSearchForm-label"> Search this site with a keyword or phrase </label>
  <input type="search" name="q" value="" id="navigationBarSearchForm-input" placeholder="Keyword or phrase"
    class="navigationBarSearchForm-input js-navigationBar-searchInput autocomplete-inputField tx-solr-q js-solr-q tx-solr-suggest tx-solr-suggest-focus form-control" autocomplete="off" style="position: relative;">
  <button aria-label="Go to search results" type="submit" value="Search" class="elementButton navigationBarSearchForm-submit u-flex u-flex--alignCenter u-flex--justifyCenter highContrast-inverted">
    <svg class="icon icon--search">
      <use xlink:href="/typo3conf/ext/site_darling_fe/Resources/Public/Images/Sprites/Dest/sprite.56515a001c.svg#searchIcon"></use>
    </svg>
  </button>
</form>

GET /search-results

<form action="/search-results" method="get" class="navigationBarSearchForm js-navigationBarSearchForm" data-suggest="/search-results?type=7384" data-hs-cf-bound="true">
  <label for="navigationBarSearchForm-input" class="show-for-sr js-navigationBarSearchForm-label"> Search this site with a keyword or phrase </label>
  <input type="search" name="q" value="" id="navigationBarSearchForm-input-maxScrollHeader" placeholder="Keyword or phrase"
    class="navigationBarSearchForm-input js-navigationBar-searchInput autocomplete-inputField tx-solr-q js-solr-q tx-solr-suggest tx-solr-suggest-focus form-control" autocomplete="off" style="position: relative;">
  <button aria-label="Go to search results" type="submit" value="Search" class="elementButton navigationBarSearchForm-submit u-flex u-flex--alignCenter u-flex--justifyCenter highContrast-inverted">
    <svg class="icon icon--search">
      <use xlink:href="/typo3conf/ext/site_darling_fe/Resources/Public/Images/Sprites/Dest/sprite.56515a001c.svg#searchIcon"></use>
    </svg>
  </button>
</form>

Text Content

We and our partners would like to use cookies and similar technologies to show
you relevant content on our and our partners websites, understand your interests
and improve our website. You can accept all cookies, select your cookies, or
reject all cookies (except necessary cookies). To find out more about the
cookies we use, please see our Privacy Policy. You may withdraw your consent at
any time by using the link in the website footer.

If you decline, your information won’t be tracked when you visit this website. A
single cookie will be used in your browser to remember your preference not to be
tracked.

Cookies settings
Accept Decline
 * Jump to content
 * Jump to navigation

 * Rousselot.com Go to Rousselot.com

 * One Team
 * Contact us
 * Current language: EN
   * PT , switch to this language
   * ES , switch to this language
   * ZH , switch to this language
 * High contrast

 * Contact us
 * Home
 * About
   * Our team
   * Contact Rousselot Biomedical
   * Locations
   * Careers
   * Events
 * Products
   * X-Pure Portfolio
   * Quali-Pure Portfolio
   * Biomedical Gelatins/Collagens
   * Quality, safety and compliance
   * Endotoxins
   * Product finder
 * Applications
   * Regenerative medicine
   * Parenteral formulation
   * Hemostatics
 * Our services
   * R&D, science
   * Regulatory support
   * Technical support
   * Co-innovation
   * Formulation support
 * Media
   * Blog/Testimonials
   * News
   * Download
   * Videos
   * Rousselot Biomedical in the press

Search this site with a keyword or phrase
Search


Menu

Close Menu
 * Contact us
 * Home
 * About
   * Previous: About
   * About
   * Our team
     * Previous: Our team
     * Our team
     * Ir. Tanja Vervust
     * Dr. Bjorn Vergauwen
     * Jos Olijve
     * Dr. Elien Gevaert
     * Dr. Jeff Daelman
     * Jeroen Geeraerts
     * Dr. Kathleen Jacobs
     * Claude Capdepon
   * Contact Rousselot Biomedical
   * Locations
   * Careers
   * Events
     * Previous: Events
     * Events
     * BioFabrication 2022
     * BIOMEDevice 2022
     * Compamed 2022
 * Products
   * Previous: Products
   * Products
   * X-Pure Portfolio
     * Previous: X-Pure Portfolio
     * X-Pure Portfolio
     * X-Pure Gelatin
     * X-Pure GelMA
     * X-Pure GelDAT
     * Customized solutions
     * Customer Product Pipeline
   * Quali-Pure Portfolio
   * Biomedical Gelatins/Collagens
   * Quality, safety and compliance
   * Endotoxins
   * Product finder
 * Applications
   * Previous: Applications
   * Applications
   * Regenerative medicine
     * Previous: Regenerative medicine
     * Regenerative medicine
     * 3D bioprinting
     * Stem cell culturing
     * Wound healing
     * Implantable membranes
     * Drug delivery
   * Parenteral formulation
   * Hemostatics
 * Our services
   * Previous: Our services
   * Our services
   * R&D, science
   * Regulatory support
   * Technical support
   * Co-innovation
   * Formulation support
 * Media
   * Previous: Media
   * Media
   * Blog/Testimonials
     * Previous: Blog/Testimonials
     * Blog/Testimonials
     * Endotoxins, an inside story
     * The Unique Properties Of Gelatin In Tissue Engineering And 3D Bioprinting
     * The importance of gelatin in pharmaceutical and medical applications
     * How Rousselot® X-Pure® low-endotoxin medical grade-gelatins can help
       tissue engineering
   * News
     * Previous: News
     * News
     * Meet us at the CRS 2022 Annual Meeting
     * Rousselot® Biomedical announces the launch of Quali-Pure HGP 2000
     * Rousselot® Biomedical announces the world's first GMP grade GelMA
     * Rousselot Announces Partnership with Terasaki Institute for Biomedical
       Innovation
     * New study confirms that purity and type of coating biomaterials used in
       2D cell culturing are crucial for efficient stem cell proliferation
     * Zerion Pharma extends its licensing agreement with Rousselot B.V to
       exploit Dispersome® technology platform
     * Rousselot® Biomedical launches Quali-Pure™
     * Antleron-Rousselot® collaborate to develop X-Pure®–by-Design
     * Rousselot Biomedical presentation highlights from the 31st conference of
       the European Society of Biomaterials conference 2021’
     * Rousselot Biomedical is open for partnering at BIO Digital 2021
     * Rousselot® Biomedical launches X-Pure® GelDAT, first ever purified and
       phenol-functionalized gelatin
     * Highly purified X-Pure gelatin creates optimal environment for stem cell
       differentiation and minimizes immune response
     * Enlight project to develop a 3D living model of pancreatic tissue
     * Webinar "Hydrogels and architecture of 3D bioprinted scaffolds for
       applications in tissue engineering"
     * Rousselot introduces X-Pure® GelMA for translational medicine
     * Join our webinar: “Optimizing Your Excipient Screening for Vaccine
       Formulation”
     * CPHI 2019: Rousselot Biomedical presents a new study on X-Pure®
     * With X-PURE®, Rousselot sets a new gelatin standard for in-body
       applications
     * A view from the Bench (by Barbara Vanhoecke)
     * Rousselot® highlights new cell viability study on X-PURE® at
       Bioconvention 2019
     * Rousselot Biomedical’s X Pure® is changing the game in purified gelatins
   * Download
     * Previous: Download
     * Download
     * Product leaflets
     * Application leaflets
     * Whitepapers
     * Research posters
   * Videos
     * Previous: Videos
     * Videos
     * Product Videos
     * Presentations, conferences
   * Rousselot Biomedical in the press
 * * Contrast mode

New blog
New blog Read our new blog

 * Contact us
 * Home
 * About
   * Our team
   * Contact Rousselot Biomedical
   * Locations
   * Careers
   * Events
 * Products
   * X-Pure Portfolio
   * Quali-Pure Portfolio
   * Biomedical Gelatins/Collagens
   * Quality, safety and compliance
   * Endotoxins
   * Product finder
 * Applications
   * Regenerative medicine
   * Parenteral formulation
   * Hemostatics
 * Our services
   * R&D, science
   * Regulatory support
   * Technical support
   * Co-innovation
   * Formulation support
 * Media
   * Blog/Testimonials
   * News
   * Download
   * Videos
   * Rousselot Biomedical in the press

Search this site with a keyword or phrase
Search


Menu

Close Menu
 * Contact us
 * Home
 * About
   * Previous: About
   * About
   * Our team
     * Previous: Our team
     * Our team
     * Ir. Tanja Vervust
     * Dr. Bjorn Vergauwen
     * Jos Olijve
     * Dr. Elien Gevaert
     * Dr. Jeff Daelman
     * Jeroen Geeraerts
     * Dr. Kathleen Jacobs
     * Claude Capdepon
   * Contact Rousselot Biomedical
   * Locations
   * Careers
   * Events
     * Previous: Events
     * Events
     * BioFabrication 2022
     * BIOMEDevice 2022
     * Compamed 2022
 * Products
   * Previous: Products
   * Products
   * X-Pure Portfolio
     * Previous: X-Pure Portfolio
     * X-Pure Portfolio
     * X-Pure Gelatin
     * X-Pure GelMA
     * X-Pure GelDAT
     * Customized solutions
     * Customer Product Pipeline
   * Quali-Pure Portfolio
   * Biomedical Gelatins/Collagens
   * Quality, safety and compliance
   * Endotoxins
   * Product finder
 * Applications
   * Previous: Applications
   * Applications
   * Regenerative medicine
     * Previous: Regenerative medicine
     * Regenerative medicine
     * 3D bioprinting
     * Stem cell culturing
     * Wound healing
     * Implantable membranes
     * Drug delivery
   * Parenteral formulation
   * Hemostatics
 * Our services
   * Previous: Our services
   * Our services
   * R&D, science
   * Regulatory support
   * Technical support
   * Co-innovation
   * Formulation support
 * Media
   * Previous: Media
   * Media
   * Blog/Testimonials
     * Previous: Blog/Testimonials
     * Blog/Testimonials
     * Endotoxins, an inside story
     * The Unique Properties Of Gelatin In Tissue Engineering And 3D Bioprinting
     * The importance of gelatin in pharmaceutical and medical applications
     * How Rousselot® X-Pure® low-endotoxin medical grade-gelatins can help
       tissue engineering
   * News
     * Previous: News
     * News
     * Meet us at the CRS 2022 Annual Meeting
     * Rousselot® Biomedical announces the launch of Quali-Pure HGP 2000
     * Rousselot® Biomedical announces the world's first GMP grade GelMA
     * Rousselot Announces Partnership with Terasaki Institute for Biomedical
       Innovation
     * New study confirms that purity and type of coating biomaterials used in
       2D cell culturing are crucial for efficient stem cell proliferation
     * Zerion Pharma extends its licensing agreement with Rousselot B.V to
       exploit Dispersome® technology platform
     * Rousselot® Biomedical launches Quali-Pure™
     * Antleron-Rousselot® collaborate to develop X-Pure®–by-Design
     * Rousselot Biomedical presentation highlights from the 31st conference of
       the European Society of Biomaterials conference 2021’
     * Rousselot Biomedical is open for partnering at BIO Digital 2021
     * Rousselot® Biomedical launches X-Pure® GelDAT, first ever purified and
       phenol-functionalized gelatin
     * Highly purified X-Pure gelatin creates optimal environment for stem cell
       differentiation and minimizes immune response
     * Enlight project to develop a 3D living model of pancreatic tissue
     * Webinar "Hydrogels and architecture of 3D bioprinted scaffolds for
       applications in tissue engineering"
     * Rousselot introduces X-Pure® GelMA for translational medicine
     * Join our webinar: “Optimizing Your Excipient Screening for Vaccine
       Formulation”
     * CPHI 2019: Rousselot Biomedical presents a new study on X-Pure®
     * With X-PURE®, Rousselot sets a new gelatin standard for in-body
       applications
     * A view from the Bench (by Barbara Vanhoecke)
     * Rousselot® highlights new cell viability study on X-PURE® at
       Bioconvention 2019
     * Rousselot Biomedical’s X Pure® is changing the game in purified gelatins
   * Download
     * Previous: Download
     * Download
     * Product leaflets
     * Application leaflets
     * Whitepapers
     * Research posters
   * Videos
     * Previous: Videos
     * Videos
     * Product Videos
     * Presentations, conferences
   * Rousselot Biomedical in the press
 * * Contrast mode


PRODUCTS

You are here:


 * X-Pure Portfolio
 * Quali-Pure Portfolio
 * Biomedical Gelatins/Collagens
 * Quality, safety and compliance
 * Endotoxins
 * Product finder

The Rousselot Biomedical team are thrilled to be attending the forthcoming
International BIO Convention 2022.

Find us at stand 2246, and let’s talk about the limitless possibilities of our
gelatins for your research or clinical applications.

 * Contact Us


ROUSSELOT BIOMEDICAL GELATINS: THE FAST TRACK TO MARKET


DESIGNED BY NATURE, PERFECTED BY ROUSSELOT

Gelatin, a biomaterial designed by nature, is widely used in human medicine. Its
natural biocompatibility and biodegradability, combined with its
customizability, make it the biomaterial of choice for a large number of
pharmaceutical and biomedical applications. However, as for any natural product,
ensuring sufficient purity and batch-to-batch consistency is key. When selecting
a gelatin-based biomaterial, it is crucial to choose high quality gelatins that
meet these criteria to give your biomedical application the best chance of
success.

With the strictest quality, consistency and regulatory documentation, Rousselot
Biomedical gelatins reduce the variability in research and clinical developments
and help you to fast-track your products to market.


FIND AN X-PURE OR QUALI-PURE GELATIN SOLUTION TODAY:


X-PURE®

The X-Pure range offers ultra-pure GMP1-grade gelatins in various types
(gelling/non-gelling) from various sources (porcine/bovine), as well as modified
gelatins like GelMA and GelDAT. Due to our unique production process, all X-Pure
products can be customized to meet the needs of your product; we can tailor the
bloom, viscosity, molecular weight, degree of modification, or produce a whole
new modification entirely.

X-Pure gelatins are ideal for research and sensitive in-body applications (such
as those related to the brain, blood, heart or eyes) due to their ultra-low
endotoxin levels (≤ 10 EU/g).

 * Discover the full range of X-Pure Gelatins.




QUALI-PURE®

Are you already using a pharmaceutical gelatin? Quali-Pure is a reliable
alternative offering the consistency you seek, as well as the regulatory
compliance you need. 

The Quali-Pure range offers endotoxin-controlled gelling and non-gelling
(hydrolyzed) gelatins. Quali-Pure is produced under GMP and comes with
documentation to support compliance towards applicable legislation, including
ISO standards and the new EU Medical Device Regulation (MDR).

 * Discover the full range of Quali-Pure Gelatins.


ENLIGHT Project

Rousselot Biomedical is supporting the European ENLIGHT project to develop a
living 3D model of the pancreas to enable better testing of diabetes medication.

 * Discover the ENLIGHT Project
 * Learn about gelatin in 3D bioprinting

Contact us to customize a solution with X-Pure or Quali-Pure today
 * Contact us today

 1.   IPEC – Excipient Good Manufacturing Practices Guide, 2017 as of end 2021

--------------------------------------------------------------------------------

ABOUT ROUSSELOT BIOMEDICAL
Our Team
Contact Rousselot Biomedical
Locations
Careers
Events


PRODUCTS
X-Pure portfolio
Quali-Pure portfolio
Biomedical gelatins/collagens
Quality, Safety and compliance
Endotoxins
Product finder

APPLICATIONS
Regenerative medicine
Parenteral formulation
Hemostatics
 

SERVICES
R&D science
Regulatory support
Technical support
Co-innovation
Formulation support

MEDIA
Blog / Testimonials
News
Downloads
Videos
Rousselot Biomedical in the press

CONTACT

 * Twitter
 * LinkedIn
 * Youtube

LOCATIONS
CAREERS 


Health


Copyright © 2022 Rousselot All Rights Reserved.

 * Terms of Use
 * Privacy policy
 * California Transparency
 * Sitemap



Sumo